Orpea's elder-care scandal wiped out 90% of its market value

In January 2022, journalist Victor Castanet published 'Les Fossoyeurs' ('The Gravediggers'), an investigative book accusing Orpea, Europe's largest for-profit elder-care group, of systematic understaffing, cost-cutting and poor hygiene that endangered residents. The book drew on internal documents and testimonies from current and former employees.

The allegations triggered public outrage, regulatory inspections and a collapse in Orpea's share price, which fell by roughly 90% over the following months. CEO Yves Le Masne resigned, and the company faced criminal investigations, lawsuits from families and pressure from the French state, which held contracts with the group.

Orpea eventually entered accelerated safeguard proceedings to restructure its debt and pledged to invest more in staffing and care quality. The episode intensified debate across Europe about the privatisation of elderly care and the conflict between profit targets and resident welfare.

The case is now used in business ethics, healthcare management and governance teaching as an example of how operational cost-cutting can destroy a company's social licence and market value at once.

The scandal erased 90% of market value, forcing restructuring and a CEO resignation, showing that cutting care costs can destroy a company's social licence and value.

Orpea's growth strategy prioritised occupancy and cost control over staffing ratios and care quality.

Management incentives aligned with financial targets rather than resident outcomes.

Regulatory oversight and whistle-blower protections were insufficient to surface problems before the book's publication.

The company treated care as a real-estate and occupancy business rather than a labour-intensive service.

In care businesses, the cost line is also a quality line. Cut staffing too far and the regulator, the families and eventually the market will notice.

Orpea's CEO departed, the shares collapsed, and the company entered restructuring while pledging care-quality investment. The scandal prompted broader scrutiny of for-profit care across Europe and is now a standard ethics case.